en   |   it

11 February 2011

Mandarin Capital Partners acquires Archimica from TowerBrook Capital Partners

Mandarin Capital Partners, through its portfolio company Euticals, acquires Archimica, the pharmaceutical fine chemical company, from TowerBrook Capital Partners. DVRCAPITAL acted as financial advisor for the acquirer

For additional information, click here

DVR Capital is a portrait site only, turn you device!